# SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid1026039
Categories: beauty, cleaning, food, industrial, pharma
Functions: Anti-scaling agent, Biocide, Chelating agent, Corrosion inhibitor, Deodorizer, Flavouring and nutrient, Fragrance, Hog Scald Agents (must be removed by subsequent cleaning operations), Other, Thickening agent, pH regulating agent, used in foods to quicken cook time
Identifier: DTXSID1026039

> SODIUM PHOSPHATE, DIBASIC, ANHYDROUS is used as anti-scaling agent / biocide. EPA CPDat observed this chemical in 1204 composition records across product categories including Laboratory supplies, Cleaning and safety, Industrial products. Assessed from 54 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 1204 composition records across product categories including Laboratory supplies, Cleaning and safety, Industrial products.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 1204 composition records across product categories including Laboratory supplies, Cleaning and safety, Industrial products. EPA CPDat classifies this chemical for functional uses including Deodorizer, pH regulating agent, Corrosion inhibitor.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM; Potency: 0.35 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 28 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 36 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Maximum daily exposure: 28 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 1751 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 139.2 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 1751 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 36 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 8 mg
- US: inactive ingredient database — Route: INTRAOCULAR; Dosage form: INSERT; Potency: 0.02 mg
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 381 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: 0.28 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 139.2 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 1751 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2460 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: LIQUID; Maximum daily exposure: 381 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 381 mg
- US: inactive ingredient database — Route: INTRAVESICAL; Dosage form: INJECTION, SOLUTION; Potency: 38.25 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SOLUTION; Potency: 5 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 7 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 1.21 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.4 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 40 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 43 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 207 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: FILM, SOLUBLE; Potency: 0.05 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 140 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 66 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 70 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 96 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 210 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.01 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Potency: 28 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.11 %w/v
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 0.09 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 0.36 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION/ DROPS; Potency: 0.14 %w/v
- US: inactive ingredient database — Route: TRANSMUCOSAL; Dosage form: LOZENGE; Maximum daily exposure: 112 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 19 active drug products and 20 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._